# A Randomized Study to Establish the Efficacy of Oral Ice Exposure During Oxaliplatin Infusion in Preventing Oral Cold Sensitivity

> **NCT03427021** · EARLY_PHASE1 · TERMINATED · sponsor: **Abramson Cancer Center at Penn Medicine** · enrollment: 65 (actual)

## Conditions studied

- GI Patients on Oxaliplatin Containing Regimen

## Interventions

- **DRUG:** Oxaliplatin

## Key facts

- **NCT ID:** NCT03427021
- **Lead sponsor:** Abramson Cancer Center at Penn Medicine
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-02-01
- **Primary completion:** 2018-10-23
- **Final completion:** 2018-10-23
- **Target enrollment:** 65 (ACTUAL)
- **Why stopped:** final study report has been completed and submitted
- **Last updated:** 2020-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03427021

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03427021, "A Randomized Study to Establish the Efficacy of Oral Ice Exposure During Oxaliplatin Infusion in Preventing Oral Cold Sensitivity". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03427021. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*